[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].Nervenarzt. 1994 Mar; 65(3):202-5.N
Abstract
We report the case of a 49-year-old woman with a therapy resistant paranoid hallucinatory psychosis and coexisting severe symptoms of Parkinson's disease. Over a 3-week period she received electroconvulsive therapy (ECT) 10 times, while the medication of haloperidol 8 mg/day, thioridazin 90 mg/day, metixen 17.5 mg/day and biperiden 6 mg/day was continued. There was a general improvement of the clinical picture, more pronounced for the parkinson symptomatology than for the psychotic disorder.
MeSH
Pub Type(s)
Case Reports
English Abstract
Journal Article
Language
ger
PubMed ID
7909917
Citation
Höflich, G, et al. "[Electroconvulsive Therapy in Comorbidity of Treatment Refractory Paranoid Hallucinatory Psychoses With Parkinson Disease]." Der Nervenarzt, vol. 65, no. 3, 1994, pp. 202-5.
Höflich G, Burghof KW, Kasper S, et al. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease]. Nervenarzt. 1994;65(3):202-5.
Höflich, G., Burghof, K. W., Kasper, S., & Möller, H. J. (1994). [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease]. Der Nervenarzt, 65(3), 202-5.
Höflich G, et al. [Electroconvulsive Therapy in Comorbidity of Treatment Refractory Paranoid Hallucinatory Psychoses With Parkinson Disease]. Nervenarzt. 1994;65(3):202-5. PubMed PMID: 7909917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
AU - Höflich,G,
AU - Burghof,K W,
AU - Kasper,S,
AU - Möller,H J,
PY - 1994/3/1/pubmed
PY - 1994/3/1/medline
PY - 1994/3/1/entrez
SP - 202
EP - 5
JF - Der Nervenarzt
JO - Nervenarzt
VL - 65
IS - 3
N2 - We report the case of a 49-year-old woman with a therapy resistant paranoid hallucinatory psychosis and coexisting severe symptoms of Parkinson's disease. Over a 3-week period she received electroconvulsive therapy (ECT) 10 times, while the medication of haloperidol 8 mg/day, thioridazin 90 mg/day, metixen 17.5 mg/day and biperiden 6 mg/day was continued. There was a general improvement of the clinical picture, more pronounced for the parkinson symptomatology than for the psychotic disorder.
SN - 0028-2804
UR - https://www.unboundmedicine.com/medline/citation/7909917/[Electroconvulsive_therapy_in_comorbidity_of_treatment_refractory_paranoid_hallucinatory_psychoses_with_Parkinson_disease]_
L2 - http://www.diseaseinfosearch.org/result/5603
DB - PRIME
DP - Unbound Medicine
ER -